DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 1 filers reported holding DYNE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 32.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,573,623 | -20.4% | 9,885,449 | 0.0% | 13.72% | -0.9% |
| Q2 2023 | $111,211,301 | -2.3% | 9,885,449 | 0.0% | 13.84% | -10.2% |
| Q1 2023 | $113,880,372 | -0.4% | 9,885,449 | +0.2% | 15.42% | +11.9% |
| Q4 2022 | $114,387,308 | +0.8% | 9,869,483 | +10.5% | 13.78% | +10.0% |
| Q3 2022 | $113,473,000 | +84.9% | 8,934,902 | 0.0% | 12.52% | +22.0% |
| Q2 2022 | $61,383,000 | -28.7% | 8,934,902 | 0.0% | 10.26% | -5.8% |
| Q1 2022 | $86,132,000 | -18.9% | 8,934,902 | 0.0% | 10.89% | +11.6% |
| Q4 2021 | $106,236,000 | – | 8,934,902 | – | 9.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $19,891,505 | 30.79% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $44,363,675 | 23.76% |
| Atlas Venture Life Science Advisors, LLC | 9,885,449 | $88,573,623 | 13.72% |
| Logos Global Management LP | 2,180,000 | $19,532,800 | 2.61% |
| TCG Crossover Management, LLC | 1,650,150 | $14,785,344 | 2.18% |
| VR Adviser, LLC | 2,173,913 | $19,478,260 | 2.05% |
| Altium Capital Management LP | 315,000 | $2,822,400 | 1.47% |
| Vivo Capital, LLC | 1,035,136 | $9,274,819 | 1.02% |
| Octagon Capital Advisors LP | 692,945 | $6,208,787 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 146,500 | $1,312,640 | 0.88% |